HomeCOLL • NASDAQ
Follow
Collegium Pharmaceutical Inc
Previous close
$40.91
Day range
$38.59 - $40.95
Year range
$20.83 - $40.95
Market cap
1.25B USD
Avg Volume
523.92K
P/E ratio
33.96
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 149.74M | 15.53% |
Operating expense | 67.46M | -11.40% |
Net income | 31.94M | 543.67% |
Net profit margin | 21.33 | 484.32% |
Earnings per share | 1.58 | 44.95% |
EBITDA | 97.15M | 38.64% |
Effective tax rate | 31.62% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 310.55M | 78.80% |
Total assets | 1.14B | -2.63% |
Total liabilities | 947.88M | -3.21% |
Total equity | 195.43M | — |
Shares outstanding | 31.96M | — |
Price to book | 6.67 | — |
Return on assets | 13.29% | — |
Return on capital | 17.46% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 31.94M | 543.67% |
Cash from operations | 73.34M | 10.57% |
Cash from investing | -25.10M | -2,569.89% |
Cash from financing | -67.83M | -162.66% |
Net change in cash | -19.58M | -149.50% |
Free cash flow | 69.52M | -8.14% |
About
Founded
2002
Website
Employees
197